0001225208-15-016754.txt : 20150812 0001225208-15-016754.hdr.sgml : 20150812 20150812163018 ACCESSION NUMBER: 0001225208-15-016754 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150810 FILED AS OF DATE: 20150812 DATE AS OF CHANGE: 20150812 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001404644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 887 GREAT NORTHERN WAY STREET 2: SUITE 450 CITY: VANCOUVER STATE: A1 ZIP: V5T 4T5 BUSINESS PHONE: 604-629-9223 MAIL ADDRESS: STREET 1: 887 GREAT NORTHERN WAY STREET 2: SUITE 450 CITY: VANCOUVER STATE: A1 ZIP: V5T 4T5 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC DATE OF NAME CHANGE: 20070626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36327 FILM NUMBER: 151047326 BUSINESS ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2125732323 MAIL ADDRESS: STREET 1: 235 E 42ND ST CITY: NEW YORK STATE: NY ZIP: 10017 FORMER NAME: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 4 1 doc4.xml X0306 4 2015-08-10 1 0001404644 AQUINOX PHARMACEUTICALS, INC AQXP 0000078003 PFIZER INC 235 EAST 42ND ST NEW YORK NY 10017 1 Common Stock 2015-08-10 4 S 0 18.0000 29.0000 D 1235312.0000 D Common Stock 2015-08-10 4 S 0 2840.0000 41.2475 D 1232472.0000 D Common Stock 2015-08-10 4 S 0 2975.0000 28.4670 D 1229497.0000 D Common Stock 2015-08-10 4 S 0 3207.0000 35.6072 D 1226290.0000 D Common Stock 2015-08-10 4 S 0 6073.0000 40.2955 D 1220217.0000 D Common Stock 2015-08-10 4 S 0 8565.0000 27.3561 D 1211652.0000 D Common Stock 2015-08-10 4 S 0 8969.0000 21.4506 D 1202683.0000 D Common Stock 2015-08-10 4 S 0 9142.0000 39.5172 D 1193541.0000 D Common Stock 2015-08-10 4 S 0 9901.0000 37.2264 D 1183640.0000 D Common Stock 2015-08-10 4 S 0 10544.0000 36.3687 D 1173096.0000 D Common Stock 2015-08-10 4 S 0 11627.0000 38.4947 D 1161469.0000 D Common Stock 2015-08-10 4 S 0 12726.0000 25.3233 D 1148743.0000 D Common Stock 2015-08-10 4 S 0 13109.0000 26.3213 D 1135634.0000 D Common Stock 2015-08-10 4 S 0 25931.0000 20.3476 D 1109703.0000 D Common Stock 2015-08-10 4 S 0 31400.0000 24.3129 D 1078303.0000 D Common Stock 2015-08-10 4 S 0 44268.0000 22.5994 D 1034035.0000 D Common Stock 2015-08-10 4 S 0 58632.0000 23.4112 D 975403.0000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.46, inclusive. The reporting person undertakes to provide to Aquinox Pharmaceuticals Inc., the "Issuer", any security holder of the Issuer, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1) through (16) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.90, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.25 to $35.94, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.99, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.90, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.01 to $21.87, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.99, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.90, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.99, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.93, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.99, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.99, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.82, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.90, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.98, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.99, inclusive. /s/ Susan Grant, Asst. Secretary of Pfizer Inc. 2015-08-12